Related Experiment Video
Updated: Aug 9, 2026
Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Relative usefulness of three growth hormone stimulation screening tests
Insights
The combined levodopa-propranolol hydrochloride test is the most effective screening method for growth hormone deficiency in children. This approach significantly reduces false positives compared to sleep or levodopa-only tests, minimizing unnecessary follow-up evaluations.
Area of Science:
- Pediatric Endocrinology
- Diagnostic Testing
- Growth Hormone Disorders
Background:
- Growth hormone deficiency (GHD) diagnosis requires accurate screening.
- Current screening methods like sleep tests and levodopa administration have limitations.
- High false-positive rates necessitate further, more invasive testing.
Purpose of the Study:
- To compare the efficacy of three screening procedures for GHD in children.
- To identify the screening method with the lowest false-positive rate.
- To optimize diagnostic pathways for pediatric GHD.
Main Methods:
- A five-year study involving 191 children.
- Evaluation of three screening procedures: sleep screen, levodopa administration, and combined levodopa-propranolol hydrochloride.
- Analysis of false-positive rates for each method.
Main Results:
- Sleep screen: 31.3% false-positive rate.
- Levodopa alone: 20.5% false-positive rate.
- Levodopa with propranolol: 5.2% false-positive rate.
Conclusions:
- The combined levodopa-propranolol hydrochloride test is significantly superior for GHD screening.
- This combination minimizes false positives, reducing the need for extensive follow-up testing.
- Optimized screening improves diagnostic efficiency in pediatric endocrinology.
Abstract:
One hundred ninety-one children were tested by one of three screening procedures for growth hormone deficiency over a five-year period. Sleep screen yielded a 31.3% false-positive rate; levodopa administration alone yielded a 20.5% false-positive rate and levodopa in combination with propranolol yielded a 5.2% false-positive rate. These results support the view that the combined levodopa-propranolol hydrochloride screen test is superior to either the sleep or the levodopa screen tests in limiting the number of false-positive results and thus the need for further, more extensive testing.
